Editorial: CT‐P13, a biosimilar of anti‐tumour necrosis factor‐alpha agent (infliximab), in inflammatory bowel diseases – authors’ reply
Y. Komaki; A. Yamada; F. Komaki; D. Micic; A. Ido; A. Sakuraba
Author Information: Section of Gastroenterology, Hepatology and Nutrition
Checking for direct PDF access through Ovid |
Abstract
Abstract unavailable for this article.